Scheme 1. Deoxyribonolactone Lesion Formation and
Scheme 2. Site-Specific Generation of DNA
Cleavage
Deoxyribonolactone Sites
deoxyribonolactone lesions in DNA. Scheme 1 shows a
generalized pathway for the formation of and subsequent
DNA strand scission at deoxyribonolactone sites. The C-1′
oxidative damage reaction is initiated by hydrogen abstrac-
tion at a deoxyribonucleotide in DNA (1, Scheme 1) to
produce a C-1′ sugar radical. Once formed, the radical species
may undergo one of several possible oxygenation pathways,
which ultimately results in the extrusion of the nucleobase
and the production of the oxidized abasic site, 2. By virtue
of its lactone character, 2 may undergo â-elimination to
produce the R,â-unsaturated lactone DNA strand, 3, and a
5′-phosphorylated DNA product (4). The ene-lactone 3 may
decompose further to produce a 3′-phosphorylated cleavage
product (5) and methylene furanone (6).
Because of the lability of the deoxyribonolactone lesion,
methods for the controlled introduction of oxidized abasic
site lesions into DNA are required. Furthermore, such
methods would provide direct experimental insight into the
chemical properties and biological effects of this oxidative
damage lesion. Existing approaches to deoxyribonolactone
lesions within DNA have relied on pathways analogous to
the natural C-1′ oxidative damage reaction. In particular,
photolysis of C-1′ tert-butyl ketone9,10 or nitroindole11
nucleoside analogues produces C-1′ deoxyribose radicals,
which are efficiently oxygenated to provide oxidized abasic
sites within DNA. These approaches have provided the first
methods for specific deoxyribonolactone generation and have
offered significant insights into the properties of these DNA
damage lesions.9g,11c
photolabile lactone precursor based upon (1) its predicted
compatibility with DNA synthesis and deprotection condi-
tions,12 (2) the expected stability of the caged analogue 8
under aqueous conditions,13 and (3) the known photochem-
istry of o-nitrobenzyl ethers.14 Thus, incorporation of ana-
logue 7 during solid-phase DNA synthesis would produce
the caged-lactone DNA (8). The o-nitrobenzyl ether of 8 then
would be cleaved by UV irradiation to produce the lactone
cyanohydrin, 9, which would be expected to decompose to
the lactone lesion within DNA (2). Herein we describe the
synthesis of caged phosphoramidite 7, its incorporation into
DNA (8), and the efficient photochemical generation and
characterization of 2-deoxyribonolactone lesions (2, Scheme
2) within DNA.
A versatile synthetic route to the caged nucleoside
analogue 7 was developed (Scheme 3). The approach
centered on the construction of a ribosyl donor, cyanobro-
mide 12, which was prepared from the known15 1-chloro-
3,5-di-p-chlorobenzoyl-D-ribofuranose (10). Conversion of
10 into C-1 cyanide (11) was accomplished by reaction with
diethylaluminum cyanide.16 Free-radical bromination of 11
with NBS produced the anomeric mixture of C-1 bromo-
cyanides 12 in 80% yield. The nitrobenzyl group was
installed using silver triflate-promoted glycosylation,17 to
produce 13 in 70% yield as a mixture of C-1′ isomers.
To convert 13 into a form suitable for automated DNA
synthesis, the 3′- and 5′-O-p-chlorobenzoyl protecting groups
were removed with methanolic ammonia18 to produce an
inseparable mixture of the anomeric nucleosides 14. Trans-
formation of 14 to the corresponding mono-methoxytrityl
We now report an efficient method for the site-specific
introduction of 2-deoxyribonolactone lesions in DNA oli-
gonucleotides that is independent of the C-1′ damage
reaction. Our approach, which is outlined in Scheme 2,
involves the generation of lactone sites within DNA from a
stable, photochemically “caged” form of the lesion. The C-1′
cyanohydrin 2-nitrobenzyl ether (7) was selected as a
(12) Ordoukhanian, P.; Taylor, J.-S. J. Am. Chem. Soc. 1995, 117, 9570-
9571.
(13) Olah, G. A.; Arvanaghi, M.; Surya Prakash, G. K. J. Am. Chem.
Soc. 1982, 104, 1628-1631.
(14) Pillai, V. N. Rajasekharan. Synthesis 1980, 1-26.
(15) Eger, K.; Jalalian, M.; Schmidt, M. Tetrahedron 1994, 50, 8371-
8380.
(16) Iyer, R.; Phillips, L.; Egan, W. Synth. Commun. 1991, 20, 2053-
2063.
(17) Buchanan, J. G.; Clelland, A. P. W.; Wightman, R. H.; Johnson,
T.; Rennie, R. A. C. Carbohydr. Res. 1992, 237, 295-301.
(18) Uteza, V.; Chen, G.; Tuoi, J.; Fenet, B.; Grouiller, A. Tetrahedron
1993, 49, 8579-8588.
(11) (a) Kotera, M.; Bourdat, A.; Defrancq, E.; Lhomme, J. J. Am. Chem.
Soc. 1998, 120, 11810-11811. (b) Kotera, M.; Bourdat, A.-G.; Defrancq,
E.; Jourdan, M.; Garcia, J.; Coulombeau, C.; Lhomme, J. Nucleosides
Nucleotides 1999, 18, 1323-1324. (c) Jourdan, M.; Garcia, J.; Defrancq,
E.; Kotera, M.; Lhomme, J. Biochemistry 1999, 38, 3985-3995. (d) Kotera,
M.; Roupioz, Y.; Defranq, E.; Bourdat, A.-G.; Garcia, J.; Coulombeau, C.;
Lhomme, J. Chem. Eur. J. 2000, 6, 4163-4169.
2416
Org. Lett., Vol. 3, No. 15, 2001